PNC FINANCIAL SERVICES GROUP, INC. - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 111 filers reported holding FIBROGEN INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$9831,139
+37866.7%
0.00%
Q2 2022$0
-100.0%
3
-97.7%
0.00%
Q1 2022$2,000132
+1550.0%
0.00%
Q4 2021$080.0%0.00%
Q3 2021$0
-100.0%
8
-66.7%
0.00%
Q2 2021$1,0000.0%24
+26.3%
0.00%
Q1 2021$1,000
-99.6%
19
-99.7%
0.00%
Q4 2020$263,000
+103.9%
7,056
+125.0%
0.00%
Q3 2020$129,000
+12800.0%
3,136
+9123.5%
0.00%
Q2 2020$1,0000.0%34
+30.8%
0.00%
Q1 2020$1,0000.0%26
+116.7%
0.00%
Q4 2019$1,000
-99.4%
12
-99.7%
0.00%
Q3 2019$157,000
-15.1%
4,255
+3.7%
0.00%
Q2 2019$185,000
+9150.0%
4,104
+9909.8%
0.00%
Q1 2019$2,000
+100.0%
41
+46.4%
0.00%
Q4 2018$1,000
-99.3%
28
-98.9%
0.00%
Q3 2018$153,000
-8.9%
2,505
-6.7%
0.00%
Q2 2018$168,000
-87.4%
2,684
-90.7%
0.00%
-100.0%
Q1 2018$1,337,000
+44466.7%
28,919
+78059.5%
0.00%
Q4 2017$3,000
+200.0%
37
+48.0%
0.00%
Q3 2017$1,000
-80.0%
25
-91.1%
0.00%
Q2 2016$5,000
-99.4%
282
-99.3%
0.00%
-100.0%
Q1 2016$883,000
-19.0%
41,489
+16.0%
0.00%0.0%
Q4 2015$1,090,000
+12011.1%
35,756
+8621.0%
0.00%
Q3 2015$9,0000.0%410
+3.5%
0.00%
Q2 2015$9,000
+800.0%
396
+1621.7%
0.00%
Q1 2015$1,000230.00%
Other shareholders
FIBROGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders